Budget 2023Budget 2023


  • Tata AIA Life Insurance
  • Hafele
  • Motilal Oswal
  • SMC Global Securities Limited
  • SBI Life
Upcoming Event : LeapToUnicorn - mentoring, networking and fundraising for startups. Register now
Budget 2023
Budget 2023
you are here: HomeNewsTrendsHealth

Pharma wrap: Why ICMR's Aug 15 deadline for COVID-19 vaccine launch is controversial

Vaccine experts raised serious concerns, calling the timelines unprecendented and unrealistic.

July 06, 2020 / 12:40 PM IST

ICMR Director General Balram Bhargava's letter to 12 principal investigators instructing them to fast-track approvals to initiate clinical trials of Bharat Biotech's COVID-19 vaccine with an aim to launch by August 15, has caused a storm in the scientific community.

ICMR and Bharat Biotech are jointly working on the preclinical as well as clinical development of this vaccine.

It is not just the deadline, the tone and tenor of the letter that warned that non-compliance will be viewed very seriously, has sparked more controversy.

Vaccine experts raised serious concerns, calling the timelines unprecedented and unrealistic.